 DERMADEX
|
GlaxoSmithKline Biopharma
|
| clobetasol |
Antieccematoso |
| cr.x 15 g | $23.660,57 | (29/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $9.464,23 AF $14.196,34 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $18.661,95 |
|
|
|
|
| ung.x 15 g | $22.422,90 | (29/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.969,16 AF $13.453,74 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $17.424,28 |
|
|
|
|
| cr.x 30 g | $46.400,96 | (29/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $18.560,38 AF $27.840,58 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $40.472,71 |
|
|
|
|
| ung.x 30 g | $42.975,60 | (29/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $17.190,24 AF $25.785,36 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $37.047,35 |
|
|
|
|
| |
